Managing cancer pain poorly responsive to systemic opioid therapy

ONCOLOGY

Volumn 13, Issue 5 SUPPL., 1999, Pages 25-29

  Portenoy, Russell K ^a,b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; OPIATE AGONIST;

CANCER PAIN; CANCER PATIENT; HUMAN; PAIN ASSESSMENT; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT FAILURE;

ANALGESICS; ANALGESICS, OPIOID; HEALTH CARE SURVEYS; HUMANS; INJECTIONS, SPINAL; NEOPLASMS; NEUROSURGICAL PROCEDURES; PAIN;

EID: 0032973603     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. World Health Organization: Cancer Pain Relief and Palliative Care. Geneva, World Health Organization, 1996.
2. Jacox A, Carr DB, Payne R, et al (eds): Management of Cancer Pain. Clinical Practice Guideline No. 9. Rockville, MD, Agency for Health Care Policy and Research, US Department of Health and Human Services, Public Health Service, AHCPR Publication No. 94-0592, March 1994.
3. Portenoy RK: Pain in Oncologic and AIDS Patients, 2nd ed. Newtown, PA, Handbooks in Health Care, 1998.
4. American Society of Clinical Oncology Ad Hoc Committee on Cancer Pain: Cancer pair assessment and treatment curriculum guidelines J Clin Oncol 10:1976-1982, 1992.
5. American College of Physicians Health and Public Policy Committee: Drug therapy for severe chronic pain in terminal illness. Ann Intern Med 99:870-873, 1983.
6. American Pain Society: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. Skokie, IL, American Pain Society, 1999.
7. Jorgensen L, Mortensen M-J, Jensen N-H, et al: Treatment of cancer pain patients in a multidisciplinary pain clinic. The Pain Clinic 3:83-89, 1990.
8. Moulin DE, Foley KM: Review of a hospital-based pain service, in Foley KM, Bonica JJ, Ventafridda V (eds): Advances in Pain Research and Therapy, vol 16, pp. 413-427. Second International Congress on Cancer Pain, New York, Raven Press, 1990.
9. Schug SA, Zech D, Dorr U: Cancer pain management according to WHO analgesic guidelines. J Pain Symptom Manage 5:27-32, 1990.
10. Schug SA, Zech D, Grond S, et al: A long-term survey of morphine in cancer pain patients. J Pain Symptom Manage 7:259-266, 1992.
11. Ventafridda V, Tamburini M, DeConno F: Comprehensive treatment in cancer pain, in Fields HL, Dubner R, Cervero F, (eds): Advances in Pain Research and Therapy, vol 9, pp. 617-628. Proceedings of the Fourth World Congress on Pain, New York, Raven Press, 1985.
12. Ventafridda V, Tamburini M, Caraceni A, et al: A validation study of the WHO method for cancer pain relief. Cancer 59:850-856, 1990.
13. Walker VA, Hoskin PJ, Hanks GW, et al: Evaluation of WHO analgesic guidelines for cancer pain in a hospital-based palliative care unit. J Pain Symptom Manage 3:145-149, 1988.
14. Cleeland CS, Gonin R, Hatfield AK, et al: Pain and its treatment in outpatients with metastatic cancer: The Eastern Cooperative Oncology Group's outpatient study. N Engl J Med 330:592-596, 1994.
15. Portenoy RK: Opioid tolerance and efficacy: Basic research and clinical observations, in Gebhardt G, et al (eds): Proceedings of the VII World Congress on Pain. Progress in Pain Research and Management, vol 2, pp. 595-619. Seattle, IASP Press, 1994.
16. Portenoy RK, Foley KM, Inturrisi CE: The nature of opioid responsiveness and its implications for neuropathic pain: New hypotheses derived from studies of opioid infusions. Pain 43:273-286, 1990.
17. Mercadante S, Portenoy RK: Opioid poorly responsive cancer pain. Part 1. Clinical considerations. J Pain Symptom Manage, in press.
18. Bruera E, Schoeller T, Wenk R, et al: A prospective multi-center assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10:348-355, 1995.
19. Cherny NI, Thaler HT, Friedlander-Klar H, et al: Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms. Neurology 44:857-861, 1994.
20. Mercadante S, Maddaloni S, Roccella S, et al: Predictive actors in advanced cancer pain treated only by analgesics. Pain 50:151-155, 1992.
21. McQuay HJ, Jadad AR, Carroll D, et al: Opioid sensitivity of chronic pain: A patient-controlled analgesia method. Anaesthesia 47:757-767, 1992.
22. Jadad AR, Carroll D, Glynn CJ, et al: Morphine responsiveness of chronic pain: Double-blind randomised crossover study with patient-controlled analgesia. Lancet 339:1367-1371, 1992.
23. Bruera E, Chadwick S, Brenneis C, et al: Methylphenidate associated with narcotics for the treatment of cancer pain. Cancer Treat Reports 71:67-70, 1987.
24. Bruera E, Miller M, Macmillan K, et al: Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 48:163-166, 1992.
25. Galer BS Coyle N, Pasternak GW, et al: Individual variability in the response to different opioids: Report of five cases. Pain 49:87-91, 1992.
26. de Stoutz ND, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378-384, 1995.
27. Derby S, Chin J, Portenoy RK: Systemic opioid therapy tor chronic cancer pain: Practical guidelines for converting drugs and routes. CNS Drugs 9(2):99-109, 1998.
28. Portenoy RK, Lesage P: Cancer pain management. Lancet, in press.
29. Cherny VI, Portenoy RK: Cancer pain: Principles of assessment and syndromes, in Wall PD, Melzack R (eds): Textbook of Pain, 3rd ed, pp. 787-823. Edinburgh, Churchill Livingstone, 1994.
30. Krames ES, Olson K: Clinical realities and economic considerations: Patient selection in intrathecal therapy. J Pain Symptom Manage 14(3):S3-S13, 1997.
31. Waldman SD, Leak DW, Kennedy LD, et al: Intraspinal opioid therapy, in Patt RB (ed): Cancer Pain, pp. 285-328. Philadelphia, JB Lippincott, 1993.
32. Nitescu P, Appelgren L, Linder LE, et al: Epidural vs intrathecal morphine-bupivacaine: Assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manage 5:18-26, 1990.
33. Hogan Q, Haddox JD, Abram S, et al: Epidural opiates and local anesthetics for the management of cancer pain. Pain 46:271-279, 1991.
34. Eisenach JC, Du Pen S, Dubois M, et al: Epidural clonidine analgesia for intractable cancer pain. Pain 61:391-399, 1995.
35. Ferrante FM, Bedder M, Caplan RA, et al: Practice guidelines for cancer pain management. A report by the American Society of Anesthesiologists' Task Force on Pain Management, Cancer Pain Section. Anesthesiology 84:1243-1257, 1996.
36. Paice JA, Penn RD, Shott S: Intraspinal morphine for chronic pain: A retrospective, multicenter study. J Pain Symptom Manage 11:71-80, 1996.
37. Hassenbusch SJ, Paice JA, Patt RB, et al: Clinical realities and economic considerations: Economics of intrathecal therapy. J Pain Symptom Manage 14(3):S36-S48, 1997.